Creative Planning
PLSE icon

Creative Planning’s Pulse Biosciences PLSE Stock Holding History

Creative Planning’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$354K Sell
16,413
-826
-5% -$15.2K ﹤0.01% 3288
2025
Q4 		$237K Sell
17,239
-2,068
-11% -$32.2K ﹤0.01% 3419
2025
Q3 		$342K Buy
19,307
+336
+2% +$5.32K ﹤0.01% 3040
2025
Q2 		$286K Buy
18,971
+3,951
+26% +$65.6K ﹤0.01% 2935
2025
Q1 		$242K Sell
15,020
-1,010
-6% -$18.8K ﹤0.01% 2920
2024
Q4 		$279K Sell
16,030
-5,880
-27% -$104K ﹤0.01% 2723
2024
Q3 		$384K Buy
21,910
+11,667
+114% +$199K ﹤0.01% 2330
2024
Q2 		$115K Buy
+10,243
New +$96.5K ﹤0.01% 2814
2017
Q3 		– Sell
-300
Closed -$10K – 3218
2017
Q2 		$10K Sell
300
-175
-37% -$4.81K ﹤0.01% 3630
2017
Q1 		$10K Buy
+475
New +$6.47K ﹤0.01% 3600

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Creative Planning's PLSE Position: Q1 2026 in Review

Creative Planning reduced its Pulse Biosciences (PLSE) stake by 4.8% in Q1 2026, selling an estimated $15.2K and leaving 16,413 shares worth $354K. The position accounts for ﹤0.01% of the portfolio, ranked #3288.

Creative Planning first reported a position in PLSE in Q1 2017 and has held it in 10 quarters since. The position peaked at $384K in Q3 2024. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Creative Planning held 16,413 shares of Pulse Biosciences worth $354K as of Q1 2026.
  • Creative Planning sold 826 Pulse Biosciences shares in Q1 2026, an estimated $15.2K.
  • Pulse Biosciences made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #3288 holding.
  • Creative Planning first reported a position in Pulse Biosciences in Q1 2017 and has held it in 10 quarters since.
  • Creative Planning's Pulse Biosciences position peaked at $384K in Q3 2024.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.